Current drug discovery is facing numerous challenges: antimicrobial resistance, increased risk of future pandemics from globalization, spiralling costs of new drugs, etc. High-throughput (HT) synthesis with robotized operations driven by AI algorithms could help to accelerate drug discovery and development, but it requires miniaturized sample volumes. The majority of new drugs entering the market are chiral. Therefore, new experimental tools are needed to probe chirality in tiny volumes. Solving a 40-years old scientific question, our team reported a new chiral optical effect that probes chirality in tiny volumes across a range of inorganic nanoparticles, randomly distributed in isotropic liquids.
|